BioCentury
ARTICLE | Clinical News

Ciclofilin preclinical data

July 13, 2015 7:00 AM UTC

In a mouse model of liver fibrosis, oral CP-431-32 for 21 days reduced fibrosis by about 55% from baseline to day 21 vs. controls (p<0.01). The cyclophilin A ( CYPA; PPIA) antagonist was well tolera...